Regulatory scientists’ work has important ramifications for public health and should be open to public scrutiny

by Shai Mulinari, Courtney Davis
Published 2018-11-01

Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of ‘deep’ product reviews...

by Shai Mulinari, Courtney Davis
Published 2017-11-01

Misleading advertising for antidepressants in Sweden: a failure of pharmaceutical industry self-regulation.

by Anna V Zetterqvist, Shai Mulinari
Published 2013-01-01

Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Au...

by Andreas Vilhelmsson, Courtney Davis, Shai Mulinari
Published 2016-01-01

Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regu...

by Anna V Zetterqvist, Juan Merlo, Shai Mulinari
Published 2015-02-01

Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)

by Piotr Ozieranski, Emily Rickard, Shai Mulinari, Marcell Csanádi
Published 2020-09-01

Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs.

by Shai Mulinari, Andreas Vilhelmsson, Emily Rickard, Piotr Ozieranski
Published 2020-01-01

Does Maternal Country of Birth Matter for Understanding Offspring's Birthweight? A Multilevel Analysis of Individual Heterogeneity in Sweden.

by Shai Mulinari, Sol Pia Juárez, Philippe Wagner, Juan Merlo
Published 2015-01-01

The tyranny of the averages and the indiscriminate use of risk factors in public health: The case of coronary heart disease

by Juan Merlo, Shai Mulinari, Maria Wemrell, SV Subramanian, Bo Hedblad
Published 2017-12-01

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries

by Alice Fabbri, Ancel.la Santos, Signe Mezinska, Shai Mulinari, Barbara Mintzes
Published 2018-06-01

Chronic Obstructive Pulmonary Disease in Sweden: An intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy

by Sten Axelsson Fisk, Shai Mulinari, Maria Wemrell, George Leckie, Raquel Perez Vicente, Juan Merlo
Published 2018-04-01